Susquehanna Portfolio Strategies’s Pulmonx LUNG Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$48.7K	Sell	37,777 -22,482	-37%	-$37.1K	﹤0.01%	951
2025 Q4	$133K	Buy	+60,259	New	+$113K	﹤0.01%	969
2025 Q3	–	Sell	-53,526	Closed	-$139K	–	1084
2025 Q2	$139K	Buy	+53,526	New	+$211K	﹤0.01%	810
2024 Q1	–	Sell	-38,898	Closed	-$496K	–	887
2023 Q4	$496K	Buy	+38,898	New	+$405K	0.01%	771

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna Portfolio Strategies's LUNG Position: Q1 2026 in Review

Susquehanna Portfolio Strategies reduced its Pulmonx (LUNG) stake by 37% in Q1 2026, selling an estimated $37.1K and leaving 37,777 shares worth $48.7K. The position accounts for ﹤0.01% of the portfolio, ranked #951.

Susquehanna Portfolio Strategies first reported a position in LUNG in Q4 2023 and has held it in 4 quarters since. The position peaked at $496K in Q4 2023. 113 funds tracked by Wall St. Rank hold LUNG as of Q1 2026.

Susquehanna Portfolio Strategies held 37,777 shares of Pulmonx worth $48.7K as of Q1 2026.
Susquehanna Portfolio Strategies sold 22,482 Pulmonx shares in Q1 2026, an estimated $37.1K.
Pulmonx made up ﹤0.01% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #951 holding.
Susquehanna Portfolio Strategies first reported a position in Pulmonx in Q4 2023 and has held it in 4 quarters since.
Susquehanna Portfolio Strategies's Pulmonx position peaked at $496K in Q4 2023.
113 funds tracked by Wall St. Rank held Pulmonx as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.